24-sulfoximine vitamin D3 compounds
US7973024B2 · kind B2 · utility
17Cited by
3References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2006 |
| Grant date | Jul 5, 2011 |
| Priority date | — |
| Expiry date | Nov 8, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel sulfoximine compounds, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the compounds of the invention are useful for treating diseases which benefit from a modulation of the levels of 1α,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.